Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization

Ophthalmology

Volumn 121, Issue 4, 2014, Pages 926-935

  Kim, Jae Hui ^a   Chang, Young Suk ^a   Kim, Jong Woo ^a   Kim, Chul Gu ^a   Yoo, Su Jin ^a   Cho, Han Ju ^a  

^a Kim's Eye Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BEVACIZUMAB; INDOCYANINE GREEN; RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CASE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; VERY ELDERLY; VISUAL ACUITY; VITREOUS HEMORRHAGE;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84897954557     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.11.004     Document Type: Article

References (31)

1. S.R. Bennett, J.C. Folk, C.F. Blodi, and M. Klugman Factors prognostic of visual outcome in patients with subretinal hemorrhage Am J Ophthalmol 109 1990 33 37
2. R.L. Avery, S. Fekrat, B.S. Hawkins, and N.M. Bressler Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration Retina 16 1996 183 189
3. A. Scupola, G. Coscas, G. Soubrane, and E. Balestrazzi Natural history of macular subretinal hemorrhage in age-related macular degeneration Ophthalmologica 213 1999 97 102
4. C.L. Haupert, B.W. McCuen II, and G.J. Jaffe et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration Am J Ophthalmol 131 2001 208 215
5. M. Kamei, Y. Tano, and T. Maeno et al. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid Am J Ophthalmol 121 1996 267 275
6. J.F. Vander, J.L. Federman, and C. Greven et al. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration Ophthalmology 98 1991 23 27
7. Submacular Surgery Trials (SST) Research Group Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13 Ophthalmology 111 2004 1993 2006
8. S.J. Bakri, J. Nickel, P. Yoganathan, and P.M. Beer Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration Ophthalmic Surg Lasers Imaging 37 2006 278 283
9. S. Ahmad, S. Bearelly, and S.S. Stinnett et al. Photodynamic therapy for predominantly hemorrhagic lesions in neovascular age-related macular degeneration Am J Ophthalmol 145 2008 1052 1057
10. A.S. Hassan, M.W. Johnson, and T.E. Schneiderman et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement Ophthalmology 106 1999 1900 1907
11. B.A. Handwerger, B.A. Blodi, and S.R. Chandra et al. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement Arch Ophthalmol 119 2001 28 32
12. T. Mizutani, T. Yasukawa, and Y. Ito et al. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator Graefes Arch Clin Exp Ophthalmol 249 2011 1153 1157
13. M. Ohji, Y. Saito, and A. Hayashi et al. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator Arch Ophthalmol 116 1998 1326 1332
14. P.J. Rosenfeld, D.M. Brown, and J.S. Heier et al. MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
15. R.L. Avery, D.J. Pieramici, and M.D. Rabena et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 2006 363 372
16. R.F. Spaide, K. Laud, and H.F. Fine et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration Retina 26 2006 383 390
17. C.B. Meyerle, K.B. Freund, and D. Iturralde et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation Retina 27 2007 451 457
18. T. Hikichi, M. Higuchi, and T. Matsushita et al. One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients Am J Ophthalmol 154 2012 117 124
19. M.A. Chang, D.V. Do, and S.B. Bressler et al. Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration Retina 30 2010 1171 1176
20. G. Shienbaum, C.A. Garcia Filho, and H.W. Flynn Jr. et al. Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy Am J Ophthalmol 155 2013 1009 1013
21. E. Stifter, S. Michels, and F. Prager et al. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage Am J Ophthalmol 144 2007 886 892
22. P. Iacono, M.B. Parodi, and U. Introini et al. Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-relatedmacular degeneration Retina 34 2014 281 287
23. H.J. Cho, K.M. Koh, and H.S. Kim et al. Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy Am J Ophthalmol 156 2013 524 531
24. I. Krebs, L. Schmetterer, and A. Boltz et al. MANTA Research Group. A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration Br J Ophthalmol 97 2013 266 271
25. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group D.F. Martin, M.G. Maguire, and S.L. Fine et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
26. L. Arias, F. Armada, and J. Donate et al. Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss Eye (Lond) 23 2009 326 333
27. A. Oliver-Fernandez, J. Bakal, and S. Segal et al. Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration Can J Ophthalmol 40 2005 313 319
28. H. Glatt, and R. Machemer Experimental subretinal hemorrhage in rabbits Am J Ophthalmol 94 1982 762 773
29. C.A. Toth, L.S. Morse, L.M. Hjelmeland, and M.B. Landers III Fibrin directs early retinal damage after experimental subretinal hemorrhage Arch Ophthalmol 109 1991 723 729
30. K. Yamashiro, K. Tomita, and A. Tsujikawa et al. Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment Am J Ophthalmol 154 2012 125 136
31. A. Laude, P.D. Cackett, and E.N. Vithana et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 29 2010 19 29